Navigation Links
Neurologix Completes Additional $7 Million Financing
Date:12/6/2010

FORT LEE, N.J., Dec. 6, 2010 /PRNewswire-FirstCall/ -- Neurologix, Inc. (OTC Bulletin Board: NRGX), a biotechnology company developing innovative gene therapies for disorders of the brain and central nervous system, today announced that it has received additional financing from three of its largest existing investors, or their affiliates: Corriente Advisors; GE Pension Trust; and Palisade Capital Management, LLC. These investors have provided a loan to Neurologix in the aggregate principal amount of $7 million.

The loan bears interest at 10% per annum, matures on October 31, 2011, and is secured by substantially all the assets of the Company. At maturity, the Company will pay an amount equal to 1.2 times the principal amount of the loan, plus accrued interest. In addition, the investors received 7-year warrants exercisable for an aggregate of 2,430,555 shares of the Company's common stock at an exercise price of $1.44 per share. The investors were granted certain preemptive rights with respect to future financings of the Company and were granted certain registration rights with respect to the shares of the Company's common stock issuable on exercise of their warrants. The loan will be automatically converted into the preferred stock issued by the Company upon a subsequent preferred equity financing of $30 million or more. MTS Securities, LLC acted as lead placement agent on the financing and Trout Capital LLC acted as an additional placement agent.

"This additional financing reflects the strong support we have from our largest shareholders and the confidence they have in our strategy, technology and ability to bring our novel Parkinson's gene therapy to market, " said Clark A. Johnson, President and Chief Executive Officer of Neurologix. "We continue to advance NLX-P101 toward commercialization and will seek additional funding to prepare for and support a pivotal Phase
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced ... on Tuesday, November 1, 2011 at 4:30 p.m. Eastern Time/1:30 ... a business and financial update and review third quarter 2011 ... may be accessed from the Investors section of the Jazz ...
... Genprex, Inc. announced today that it will be presenting ... in San Francisco.   Greg Heinlein , Chief Operating and Financial ... Investor Forum , on October 25 starting at 11 a.m. PDT ... will be made available on the company,s website under the News ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2
(Date:5/23/2013)... 23, 2013) Treating pediatric leukemia patients with a ... dose during initial treatment may result in high survival ... the results of a study published online ... of the American Society of Hematology (ASH). ... common form of leukemia in children, is a blood ...
(Date:5/23/2013)... Henry Ford Hospital found "substantial evidence" that a regenerative ... could hold the key to better functional recovery by ... to those who suffer stroke, the leading cause of ... some ability to voluntarily use their hands and other ... one side of their bodies, while a substantial number ...
(Date:5/23/2013)... Alachua, FL (PRWEB) May 23, 2013 ... leading regenerative medicine company focused on the commercialization ... reconstruction and regeneration, today announced that the Company ... $1.1 million grant, for which AxoGen’s portion is ... Programs administrated by the U.S. Department of Defense ...
(Date:5/23/2013)... May 23, 2013 Hile Design LLC ... firm was awarded a Silver Creative Award at the ... The winning entry was for its “Open Doors” animation ... of Show” in the 2013 District 6 ADDY Awards ... The Summit Creative Award recognizes and celebrates the creative ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
Breaking Medicine News(10 mins):Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 2Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 3Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 2Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 3Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2
... ... USA offers two for one deal on summits. Also book your room before the ... ... Biopolymers Symposium 2009 conference and exhibit, taking place at the Embassy Suites Downtown Lakefront, in ...
... , , , ... Tim Gunn, television host and fashion consultant ("Project Runway," "Tim Gunn,s Guide ... the Ad dressing Psoriasis(TM) Fashion Show, sponsored by Amgen and Wyeth, ... severe plaque psoriasis who have not allowed the condition to inhibit their ...
... greater alcohol consumption, study shows , WEDNESDAY, Sept. 2 (HealthDay ... intoxicated students and more health and safety problems, new research ... and the results can be injury, violence and even death. ... at college bars and found that cheap drinks come with ...
... before 65, study finds, many younger patients not getting ... could be affecting Americans earlier in life than ever ... longer an affliction of old age," said lead researcher ... neurology and investigator for the Cognitive Rehabilitation Research Group ...
... , , MURRIETA, Calif., ... its ABTTC Inc. division, provides drug and alcohol rehabilitation and ... levels of accreditation, announced today that its co-founder and CEO, ... Company,s recent successes, management team and shareholder relations. , ...
... , Pfizer to Pay $2.3 Billion ... Sept. 2 American pharmaceutical giant Pfizer Inc. and its subsidiary ... pay $2.3 billion, the largest health care fraud settlement in the ... liability arising from the illegal promotion of certain pharmaceutical products, the ...
Cached Medicine News:Health News:Biopolymers Symposium 2009 Offers Two for One Deal: Attend Retailers Scorecard Seminar and Attend the EcoLabeling Summit Free 2Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 2Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 3Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 4Health News:Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis 5Health News:College Students Get More Drunk When Drinks Are Cheap 2Health News:Stroke May Be Striking at a Younger Age 2Health News:Stroke May Be Striking at a Younger Age 3Health News:Forterus Inc. Treatment Centers Showing Consistent, Sustainable Growth; CEO Paul Howarth Interviewed 2Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 2Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 3Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 4Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 5Health News:Justice Department Announces Largest Health Care Fraud Settlement in its History 6
... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
... The NGAL ELISA Kit is intended for ... (e.g. plasma, serum, urine), tissue extracts or ... dramatically increased, especially in urine, as early ... in ongoing renal repair processes. NGAL expression ...
... Light Head is clearly the favorite for ... 36-inch arms, the dual light heads rotate ... stability, providing unlimited positioning. Engineered construction prevents ... ranging from minimally invasive through trauma to ...
... offers all the performance of a major surgical ... use in Outpatient Settings, Minor Procedure Rooms, C-Section, ... single lights either side of the OR table ... General OR when combining Flat Screen LCD Monitors ...
Medicine Products: